Castleark Management LLC Makes New Investment in HealthEquity, Inc. $HQY

Castleark Management LLC bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 48,510 shares of the company’s stock, valued at approximately $4,054,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sivia Capital Partners LLC purchased a new position in shares of HealthEquity during the 2nd quarter valued at about $306,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of HealthEquity during the second quarter worth about $4,747,000. Marshall Wace LLP purchased a new stake in shares of HealthEquity during the second quarter worth about $5,483,000. Amundi raised its stake in HealthEquity by 9.3% during the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after purchasing an additional 2,574 shares during the period. Finally, Jump Financial LLC purchased a new stake in HealthEquity during the 2nd quarter valued at approximately $449,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on HQY shares. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Citizens Jmp raised their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Finally, BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $99.05 on Tuesday. The company has a market capitalization of $8.28 billion, a price-to-earnings ratio of 37.10, a PEG ratio of 1.59 and a beta of 0.21. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $105.96. The firm’s 50-day moving average is $90.53 and its 200 day moving average is $84.90. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the transaction, the executive vice president owned 91,141 shares in the company, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock worth $1,651,280 in the last three months. Corporate insiders own 1.60% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.